Impact BioMedical Inc - IBO Expected Profit

Public company logo of Impact BioMedical (IBO)

Does the modernization of laboratories enable the synthesis of new molecules? Impact BioMedical Inc (IBO) is developing a B2B platform to combat infections and resistant fungi using natural compounds. However, fragmented assets and a high burn rate create financial risks. The company's profit expectations reflect current dynamics, where the indicator level stands at 0.00, helping to filter out market noise and assess business sustainability.

IBO - Impact BioMedical, Inc. Future Net Profit over the range 09/17/2024 - 09/21/2024

Metric breakdowns and analytics for impactbiomedinc.com (IBO)

Fundamental company valuation:Impact BioMedical, Inc., IBO
Finished products of Impact BioMedical Inc

Projected net income assesses the future financial efficiency of the enterprise, determining its investment attractiveness. This metric calculates expected cash flow, reacting to market expectations and stress scenarios. The dynamics of this analytical profit forecast reveal the business's margin of safety in real-time. For Impact BioMedical Inc (IBO), such calculations reflect the monetization potential of its patent portfolio. The company's licensing strategy allows it to stabilize these expectations, avoiding direct pricing conflicts with competitors.

Competitor analysis

Future Profit HLN|Projected Future Earnings Kenvue Corp|Future Profit VRNA (Verona Pharma Corp)|MENS (Jyong Bio) - Expected Net Income|Expected Profit Ligand Pharmaceuticals Incorporated LGND|Amneal (AMRX) - Expected Net Profit|PRGO: Future Profit|Alvotech SA - Future Net Profit|LQDA: Projected Future Earnings|Galapagos Genomics - Expected Net Income|ANIP (ANI Pharmaceuticals Inc) - Projected Future Earnings|Expected Net Profit mannkindcorp.com MNKD|Expected Profit Amphastar Pharmaceuticals, Inc. (AMPH)|PCRX (Pacira Pharmaceuticals) - Expected Net Income|Projected Future Earnings SPRY (ARS Pharmaceuticals Inc)|Future Net Profit TBPH (Theravance)|AQST - Expected Profit|scPharmaceuticals (SCPH) - Future Profit|TECX: Projected Future Earnings|Net Profit Forecast TNXP|Expected Profit China SXT Pharmaceuticals, Inc.|EPRX: Expected Net Income|Projected Future Earnings BHST|EXOZ - Expected Net Profit|Projected Future Earnings ORMP (oramed.com)|Projected Future Earnings enterabio.com ENTX|HYFT - Expected Profit|Company Profit Forecast ABVC BioPharma, Inc ABVC|CPIX: Projected Future Earnings|Quantum BioPharma Ltd - Expected Net Income|Future Profit FGEN|Telomir Pharmaceuticals, Inc. - Forward Earnings|Projected Future Earnings RANI|SNYR (Synergy CHC) - Expected Net Income|Expected Profit Rallybio RLYB|Lexaria Bioscience (LEXX) - Expected Net Profit|PULM - Expected Profit|Company Profit Forecast Pheton Holdings PTHL|APM (Aptorum) - Future Profit|Lyra Therapeutics, Inc. (LYRA) - Projected Future Earnings|Future Profit TNFA|Net Profit Forecast YCBD (cbdmd.com)|Future Profit PRFX (PainReform Ltd)|CYTO: Forward Earnings|Projected Future Earnings LIPO (lipella.com)|Future Net Profit OPTN (OptiNose Corp)|PIRS: Future Profit|PROC - Projected Future Earnings|PTPI: Projected Future Earnings|Qilian International Holding Group (QLI) - Projected Future Earnings|SLRN (ACELYRIN, Inc.) - Projected Future Earnings|TFF Pharmaceuticals (TFFP) - Company Profit Forecast